Flipping the script: could changing the order of cancer drugs make a difference?
NCT ID NCT03069937
Summary
This study tested if starting a chemotherapy drug (docetaxel) before a hormone-blocking therapy (degarelix) works better for men newly diagnosed with prostate cancer that has spread. Both drugs are already approved, but they are usually given in the opposite order. The trial enrolled 52 men to see if this new sequence could better control the cancer by measuring PSA levels and tracking how long the treatment worked.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Conditions
Explore the condition pages connected to this study.